Intensive Care at the Royal Liverpool University Hospital   QR code

Royal Liverpool and Broadgreen University Hospitals NHS Trust The University of Liverpool The National Health Service

Members only section


Directorate of Intensive Therapy

...on the World Wide Web since 1995...

About the ICU


Contacting us

Medical Staff

Nursing Staff & Outreach 

Other Staff

Education and Training

Research, Development and Audit


The Hospital



The Intensive Care Unit (ICU) [photo] is situated on the 1st floor of the Hospital, XYZ side. It moved into its present accommodation in 1992. 

We also staff a 10 bed High Dependency Unit on the 8th floor (8B-HDU) that was opened in late 2009. HDU admitted 691 patients in 2014.

Critical Care is a separate Clinical Directorate with an annual budget of about £7M (€10M) within the Royal Liverpool University Hospital, an acute teaching hospital with an annual budget of £400M (€460M), close to Liverpool City centre.

               Contacting us

ICU Secretary: Helen Allanson: 0151 706 3191 or 0151 706 3853

Who can be e-mailed with the format:

The ICU direct line: 0151 706 2400

The CCOT direct line: 0151 706 5813


[If calling from overseas dial: + 44 151 706 XXXX]


Department of Intensive Care, 12th Floor, Royal Liverpool University Hospital, Prescot Street, LIVERPOOL, L7 8XP


Back to the top.

Medical Staff


The Clinical Director of Intensive Care:

The other Consultant Intensivist Staff are:


Staff can be e-mailed with the format:


The consultant staff are supported by one or two Clinical Fellows (12 months' post), currently Drs. Kate Tizard, and Beccy Gale as well as other trainees who operate on a shift system designed to produce an average working week of 48 hours:

Trainees are seconded from The Department of Anaesthesia and frequently from other departments such as Acute Medicine and Respiratory Medicine as well as "Common Stem" trainees. We also train about six Foundation Year doctors.

The Intensive Care staff have also managed the hospital's High Dependency Unit (located in 8B-HDU) since late 2009 (691 admissions in 2014)

The Department of Anaesthesia's medical staff manage the Hospital's Post-operative Critical Care Unit (POCCU) (609 admissions in 2014)


Back to the top.

About the ICU

Back to the top.

Research, Development and Audit

Recently completed studies and studies in follow-up

RAIN  (Risk Adjustment In Neuro-critical care)

    A NIHR HTA and ICNARC supported Multi-centre study to provide an accurate risk prediction model for TBI to aid clinicians in evaluating:

• Clinical outcome

• Effectiveness of care

• The best time to transfer to a Neuroscience Centre     and whether to transfer

• Cost-effectiveness of care and transfer



(SPOT)light  (Sepsis Pathophysiological &   Organisational Timing)

A Wellcome Trust and ICNARC supported multi-centre, prospective observational study to measure how timing of critical care affects outcome.         


Using P4 peptide to augment ex vivo phagocyte function in patients with severe community acquired pneumonia

A UK Multi–Centre Study building on previous studies in healthy volunteers and patients in intensive care with severe community acquired pneumonia. This additional study will test P4 (adjuvant therapy) during the early and latent phases of sepsis in a wider spectrum of infection than previous studies in order to identify potential therapeutic targets.

UKCRN ID 15756

Sponsors. Royal Liverpool University Hospital, Aintree University Hospitals.

Site P.I. Dr Ingeborg Welters

Haemorrhage Alleviation with Tranexamic Acid [HALT-IT]

An International Randomised, Double Blind Placebo Controlled Trial of Tranexamic Acid for the Treatment of Gastrointestinal Haemorrhage.

UKCRN ID 13965

Sponsor. London School of Hygiene and Tropical Medicine

Site P.I.  Dr.Wojciech Sawicki


A Prospective Study of aPTT Waveform and Lipoprotein - Complexed C reactive Protein Assays in the Early Diagnosis and Prognosis of     Sepsis

    A BRC supported study in collaboration with the University of Liverpool’s Department of Haematology.

 Contributors to the World Federation of Societies of Intensive and Critical Care Medicine ICON (Intensive Care over Nations ‘ICON “ Audit, 2012)

ESICM LUNG-SAFE (Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE) 2014.

ZORO (IV Zanamavir versus ORal Oseltamivir)

A phase III international, randomized, double blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamavir twice daily compared to 75 mg of oral oseltamivir twice daily in the treatment of hospitalized adults and adolescents with influenza

UKCRN ID: 9916.   Sponsor: Glaxo Smith Kline.  Site P.I.: Dr Richard Wenstone.

Current studies

Immune modulators for the early diagnosis of sepsis

 An International Multi Centre study to investigate immune modulators for the early diagnosis of sepsis in patients undergoing major elective surgery.

UKCRN ID:  6825.   Sponsor: DstL.   Site P.I.s: Dr Jonathan Walker, Dr Richard Wenstone


HARP-2  (Hydroxy methyl glutaryl-CoA Reductase Inhibition with Simvastatin in Acute Lung Injury to Reduce Pulmonary Dysfunction.

A multi-centre study to test the hypothesis that treatment with simvastatin 80mg once daily for a maximum of 28 days will be of therapeutic value in patients with acute lung injury (ALI)

UKCRN ID:  9122.  Sponsor: Belfast Health and Social Care Trust,   Site P.I.: Dr Ingeborg Welters



I-Prime (Isovolumic contraction velocity. Improving echocardiography in the critical care setting and predicting outcomes)

A 2-Centre study aiming to assess feasibility of using isovolumic contraction velocity (IVCV) in the critical care setting.

UKCRN ID: na.  Sponsors: Aintree University Hospitals, Royal Liverpool University Hospital.   Site P.I.: Dr Ingeborg Welters.


CRP-VLDL in Sepsis

A single centre study examining the clinical, diagnostic and treatment relevance of Complexes between C-reactive Protein and Very Low Density Lipoprotein in Patients with Sepsis.

UKCRN ID:  14508.   Sponsor:  Liverpool University.  Site P.I.: Dr Ingeborg Welters


ART- 123

A phase III, international, randomised, double–blind, placebo–controlled study to assess the safety and efficacy of ART-123 in subjects with severe sepsis and coagulopathy.

UKCRN ID:  13862.  Sponsor:  Asahi Kasei Pharma America Corporation.  Site P.I.: Dr Ingeborg Welters



Muscle Wasting in Critical Care


A single centre pilot study using ultrasound technology to assess changes in muscle mass in critical illness.


UKCRN ID: na. Sponsor:  Royal Liverpool University Hospital.  Site Investigators: Dr Ingeborg Welters, Dr Peter Turton




James Lind Alliance Priority Setting Project


The Intensive Care Priority Setting Partnership aims to identify and prioritise the unanswered questions about intensive care from the perspectives of people who have experienced critical illness, their families, carers, health care professionals and other interested members of the community.  This will help direct future research according to what is most important to those affected.

The partnership is being led by the Intensive Care Foundation and is being supported by the James Lind Alliance (JLA).

The JLA is a non-profit initiative of the National Institute of Health Research, which, brings patients, families, and clinicians together to identify and prioritise the unanswered questions about treatments that they agree are most important. This information will help ensure that those who fund health research are aware of what matters to both patients and clinicians.



A prospective Observational Study of Ventilation Discontinuation Practices among critically ill adults who receive mechanical ventilation for at least 24 hours in 150 international ICUs.


Sponsor. Canadian Institutes of Health Research

Site P.I.  Dr. Peter Hampshire.


Back to the top.


Nursing Staff & Critical Care Outreach


The above may be contacted by e-mail [with the format:] or by by telephone [ICU direct line: 0151 706 2400; CCOT direct line: 0151 706 5813]

Back tothe top.

Other Staff

As well as Medical, Nursing, Physiotherapy and Medical Engineering Staff, the Unit is complemented by a specialist technician (Operating Department Practitioner), John Murphy.

Back to the top.

Education and Training

Dr Nagaraj can provide further information about the Certificate of Completion of Specialist Training (CCST) in Intensive Care Medicine, as advised by the Intercollegiate Board for Training in Intensive Care Medicine (IBTICM). Further information is also available from the Intensive Care Society.



Back to the top.

About Critical Care in our local area:


Leave a Comment

WebMaster: RW


Page last updated: 05 Oct2015
This site is hosted by Compulink Information Exchange    

LegalPolicy & legal stuffstuff
© Copyright 1996--2016 by the RLUH ICU and R.Wenstone.

Back to the top.